The very first dose of the said Pfizer vaccine is reportedly 85% effective according to a study by healthcare workers over at an Israeli hospital. This could potentially fuel a debate over the said recommended two-dose schedule as the government is trying to sketch out supplies.
Study by Sheba Medical Center
The official Sheba Medical Center's reported findings compare overall efficiency of about 95% for the two dose regimen taking place 21 days from each shot developed along with BioNTech from Germany. According to the story by Reuters, the said Sheba study, which is to be published in the official The Lancet medical journal, would come a day after certain Canadian researchers had suggested that the Pfizer vaccine second dose be delayed due to the high level of protection from the initial shot in order to increase the total number of people getting the supposed vaccine.
Their own research had shown a 92.6% efficiency after the initial dose based on the analysis of the documents that were submitted by the said drugmaker from its very own late-stage human trials towards the United States FDA back in December. The FDA then noted that data from the trials showed that the vaccine actually started conferring some protection to the participants before they have even received the said second dose. More data, however, would still be needed in order to assess the single-dose shot's potential.
Is Pfizer vaccine effective?
Pfizer noted that the alternative dosing regimens of the said vaccine have yet to be evaluated and the final decision still falls on health authorities. Sheba noted that among the 7,214 staff that have received the first dose back in January, there was reportedly an 85% reduction in the symptomatic COVID section within 15 up to 28 days. The overall reduction of infections which included the asymptomatic cases that were detected through testing was at 75%.
According to a certain Sheba epidemiologist known as Gili Regev-Yochay noted that the said cohort studied at the hospital were actually mostly young and healthy. Pfizer then declined to comment on the given data in a statement noting it was doing its very own analysis of the said real-world effectiveness of the vaccine in different locations around the world, this included Israel.
Read Also: Philadelphia Vaccine Scandal: Philly Fighting COVID Is a Tale of Inexperienced Startup Company
Israel vaccinates two-thirds of its population
According to RepublicWorld, Israel recently said that the country has already inoculated a whopping four million of its people with at least one dose of the COVID-19 vaccine. This implies that the country was able to administer doses among the reported two-third of their total population.
The Health Minister Yuli Edelstein mentioned to the state-run press that Israel has actually been able to achieve the landmark threshold of 4 million meaning 2,612,000 have reportedly received the second dose. It was also noted that Israel was already able to vaccinate close to a whopping 156,000 people daily as of February 16.
Related Article: 'Confidential' Document Shows Diagram of 5G Chip Within COVID-19 Vaccine, But Truth is Far From It
This article is owned by Tech Times
Written by Urian Buenconsejo
